The company is India's largest producer of hydrogen peroxide, which it manufactures at an integrated plant in Maharashtra for use as a bleaching and oxidizing agent in the textile, paper, and water treatment industries.
While the company claims a moat based on being the largest domestic producer, the lack of pricing power is evident as margins collapsed from 21% to 6.7% when new domestic capacity entered the market. The product is a commodity, and returns on capital are currently below the cost of capital, contradicting the narrative of a durable competitive advantage.
Recent years show significant capital expenditure on capacity expansion and efficiency projects that have yet to yield satisfactory returns. The company suspended dividends in FY25 following a net loss, reflecting a pivot toward liquidity preservation over shareholder returns.
The investment collapsed as the company's commodity trap snapped shut. Despite aggressive capital expenditure to expand capacity, the market became permanently oversupplied by domestic rivals, stripping away what little pricing power remained. The negative revenue growth trend accelerated, and the lack of a cost advantage meant the company continued to earn returns well below its cost of capital. Liquidity was further drained by the crystallization of large contingent tax liabilities and ongoing related-party entanglements, leaving the business a hollowed-out shell of its former self with no dividends to compensate shareholders for the risk.
RichFakir rates National Peroxide Ltd's business quality as poor — 27/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, National Peroxide Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on National Peroxide Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of National Peroxide Ltd's fair value is about ₹219 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →